Search

everythinglearnresearchcommunity

for

Search:↓

Fibrosis in the bulge area of hair follicles can cause hair thinning in male pattern baldness, and drugs that inhibit fibrosis might help reverse this.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

TNF-a may not be as involved in certain types of hair loss as previously thought.

Dermoscopic features can help distinguish female androgenetic alopecia from telogen effluvium and healthy controls.

Hypothyroidism and hyperprolactinemia may cause hair loss in women.

The conclusion is that more women in their forties are getting AGA and stress is linked to AGA in both men and women.

Trichodysplasia spinulosa is a rare skin condition caused by a virus, treatable with antiviral medication.

Androgenetic alopecia is more common in men, linked to genetics and androgen levels, but routine pelvic ultrasound isn't recommended.

Traumatic anserine folliculosis is a harmless skin condition in young males that needs correct diagnosis to avoid unnecessary treatments.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

A 5-year-old boy was diagnosed with congenital triangular alopecia, a type of hair loss without skin changes, usually starting between ages 2-5, with no specific treatment.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Hair loss in both Androgenetic Alopecia and Alopecia Areata is often accompanied by inflammation around hair follicles, but the location and severity of this inflammation varies.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Androgenetic alopecia is a common type of hair loss in men and women, caused by a testosterone byproduct affecting hair follicles, with sensitivity determined by genetics.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Treatment with vitamin A did not improve the child's skin condition.

Surgery successfully treated a hidden ovarian tumor causing hair loss and excess hair growth in a postmenopausal woman.

Female androgenetic alopecia is a type of hair loss in women, sometimes linked to other symptoms.

Early hair loss may indicate prostate issues.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Botulinum toxin A can help improve thin endometrium and embryo implantation.

Follicular vitiligo causes hair to gray without skin color loss.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

High calcium in their diet caused zinc deficiency in the goats.

Proteoglycan replacement therapy improved hair conditions in most patients with alopecia.